08.11.2026 03:07 UTC · Market News Feed

J&J UNVEILS NEW PHASE 2 NIPOCALIMAB DATA HIGHLIGHTING PATIENT-PRIORITISED SYMPTOM IMPROVEMENTS IN SJÖGREN'S DISEASE

Türkçe

J&J, SJÖGREN HASTALIĞINDA HASTA ÖNCELİKLİ SEMPTOM İYİLEŞMELERİNİ VURGULAYAN YENİ FAZ 2 NİPOCALİMAB VERİLERİNİ AÇIKLADI.

Breaking crypto & TradFi news, the moment it happens

Open Pike News ✈ Pike Feeds English ✈ Pike Feeds TR Türkçe